Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-27

FDA Tentative Approval: AZELASTINE HYDROCHLORIDE — Original Application (Aurohealth LLC)

View source ↗

Summary

FDA issued tentative approval for Aurohealth LLC's azelastine hydrochloride nasal spray (ANDA 216561), a generic product intended for allergic rhinitis, subject…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelastine hydrochloride nasal spray (AZELASTINE HYDROCHLORIDE)

Snippet

ORIG TA for AZELASTINE HYDROCHLORIDE (AZELASTINE HYDROCHLORIDE)